BTIG maintains Buy rating on Haemonetics, $130 target
BTIG maintained its Buy rating on Haemonetics and kept a $130.00 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.